ALNY logo

Alnylam Pharmaceuticals (ALNY) Retained earnings

annual retained earnings:

-$7.29B-$278.16M(-3.97%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ALNY annual retained earnings is -$7.29 billion, with the most recent change of -$278.16 million (-3.97%) on December 31, 2024.
  • During the last 3 years, ALNY annual retained earnings has fallen by -$1.85 billion (-34.01%).
  • ALNY annual retained earnings is now -162391.59% below its all-time high of -$4.49 million, reached on December 31, 2002.

Performance

ALNY Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

quarterly retained earnings:

-$7.35B-$57.48M(-0.79%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ALNY quarterly retained earnings is -$7.35 billion, with the most recent change of -$57.48 million (-0.79%) on March 31, 2025.
  • Over the past year, ALNY quarterly retained earnings has dropped by -$269.70 million (-3.81%).
  • ALNY quarterly retained earnings is now -24783.89% below its all-time high of -$29.52 million, reached on December 31, 2003.

Performance

ALNY quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

ALNY Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.0%-3.8%
3 y3 years-34.0%-29.4%
5 y5 years-95.5%-87.9%

ALNY Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-34.0%at low-29.4%at low
5 y5-year-95.5%at low-87.9%at low
alltimeall time<-9999.0%at low<-9999.0%at low

ALNY Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$7.35B(+0.8%)
Dec 2024
-$7.29B(+4.0%)
-$7.29B(+1.2%)
Sep 2024
-
-$7.20B(+1.6%)
Jun 2024
-
-$7.09B(+0.2%)
Mar 2024
-
-$7.08B(+0.9%)
Dec 2023
-$7.01B(+6.7%)
-$7.01B(+2.0%)
Sep 2023
-
-$6.87B(-2.1%)
Jun 2023
-
-$7.02B(+4.1%)
Mar 2023
-
-$6.74B(+2.7%)
Dec 2022
-$6.57B(+20.8%)
-$6.57B(+3.3%)
Sep 2022
-
-$6.36B(+6.8%)
Jun 2022
-
-$5.96B(+4.9%)
Mar 2022
-
-$5.68B(+4.4%)
Dec 2021
-$5.44B(+18.6%)
-$5.44B(+5.0%)
Sep 2021
-
-$5.18B(+4.1%)
Jun 2021
-
-$4.98B(+4.0%)
Mar 2021
-
-$4.79B(+4.4%)
Dec 2020
-$4.59B(+23.0%)
-$4.59B(+5.6%)
Sep 2020
-
-$4.34B(+6.2%)
Jun 2020
-
-$4.09B(+4.6%)
Mar 2020
-
-$3.91B(+4.9%)
Dec 2019
-$3.73B(+31.2%)
-$3.73B(+8.0%)
Sep 2019
-
-$3.45B(+6.4%)
Jun 2019
-
-$3.24B(+7.3%)
Mar 2019
-
-$3.02B(+6.4%)
Dec 2018
-$2.84B(+32.3%)
-$2.84B(+8.0%)
Sep 2018
-
-$2.63B(+10.3%)
Jun 2018
-
-$2.38B(+7.4%)
Mar 2018
-
-$2.22B(+3.4%)
Dec 2017
-$2.15B(+29.6%)
-$2.15B(+7.1%)
Sep 2017
-
-$2.01B(+6.5%)
Jun 2017
-
-$1.88B(+6.7%)
Mar 2017
-
-$1.76B(+6.5%)
Dec 2016
-$1.66B(+32.9%)
-$1.66B(+7.3%)
Sep 2016
-
-$1.54B(+7.2%)
Jun 2016
-
-$1.44B(+6.7%)
Mar 2016
-
-$1.35B(+8.3%)
Dec 2015
-$1.25B(+30.3%)
-$1.25B(+7.8%)
Sep 2015
-
-$1.16B(+7.1%)
Jun 2015
-
-$1.08B(+7.1%)
Mar 2015
-
-$1.01B(+5.3%)
Dec 2014
-$956.63M
-$956.63M(+2.3%)
Sep 2014
-
-$935.24M(+4.9%)
DateAnnualQuarterly
Jun 2014
-
-$891.25M(+5.2%)
Mar 2014
-
-$847.18M(+42.1%)
Dec 2013
-$596.24M(+17.6%)
-$596.24M(+5.7%)
Sep 2013
-
-$563.88M(+5.6%)
Jun 2013
-
-$534.19M(+3.5%)
Mar 2013
-
-$516.02M(+1.8%)
Dec 2012
-$507.01M(+26.4%)
-$507.01M(+14.0%)
Sep 2012
-
-$444.82M(+4.6%)
Jun 2012
-
-$425.32M(+3.1%)
Mar 2012
-
-$412.36M(+2.8%)
Dec 2011
-$401.00M(+16.8%)
-$401.00M(+3.7%)
Sep 2011
-
-$386.69M(+3.5%)
Jun 2011
-
-$373.46M(+3.8%)
Mar 2011
-
-$359.63M(+4.7%)
Dec 2010
-$343.35M(+14.5%)
-$343.35M(+2.1%)
Sep 2010
-
-$336.42M(+2.9%)
Jun 2010
-
-$326.79M(+4.7%)
Mar 2010
-
-$312.15M(+4.1%)
Dec 2009
-$299.83M(+18.9%)
-$299.83M(+2.7%)
Sep 2009
-
-$292.04M(+3.3%)
Jun 2009
-
-$282.83M(+8.7%)
Mar 2009
-
-$260.13M(+3.1%)
Dec 2008
-$252.24M(+11.6%)
-$252.24M(+3.9%)
Sep 2008
-
-$242.85M(+1.2%)
Jun 2008
-
-$239.99M(+5.6%)
Mar 2008
-
-$227.23M(+0.5%)
Dec 2007
-$225.99M(+60.8%)
-$225.99M(-0.7%)
Sep 2007
-
-$227.66M(+30.2%)
Jun 2007
-
-$174.86M(+7.8%)
Mar 2007
-
-$162.17M(+15.4%)
Dec 2006
-$140.53M(+32.7%)
-$140.53M(+6.4%)
Sep 2006
-
-$132.09M(+5.9%)
Jun 2006
-
-$124.69M(+8.6%)
Mar 2006
-
-$114.78M(+8.4%)
Dec 2005
-$105.92M(+68.1%)
-$105.92M(+15.8%)
Sep 2005
-
-$91.43M(+13.2%)
Jun 2005
-
-$80.75M(+16.0%)
Mar 2005
-
-$69.60M(+10.5%)
Dec 2004
-$63.01M(+113.4%)
-$63.01M(+9.9%)
Sep 2004
-
-$57.30M(+12.6%)
Jun 2004
-
-$50.89M(+15.8%)
Mar 2004
-
-$43.93M(+48.8%)
Dec 2003
-$29.52M(+558.1%)
-$29.52M
Dec 2002
-$4.49M
-

FAQ

  • What is Alnylam Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual retained earnings year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly retained earnings year-on-year change?

What is Alnylam Pharmaceuticals annual retained earnings?

The current annual retained earnings of ALNY is -$7.29B

What is the all time high annual retained earnings for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual retained earnings is -$4.49M

What is Alnylam Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, ALNY annual retained earnings has changed by -$278.16M (-3.97%)

What is Alnylam Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of ALNY is -$7.35B

What is the all time high quarterly retained earnings for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly retained earnings is -$29.52M

What is Alnylam Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, ALNY quarterly retained earnings has changed by -$269.70M (-3.81%)
On this page